Biotech · Private company
Visterra, Inc.
Track this companyFree. Adds Visterra, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- High dose of VIS410Phase 2 · Influenza AClinicalTrials.gov · fetched Nov 12, 2026
- Low dose of VIS410Phase 2 · Influenza AClinicalTrials.gov · fetched Nov 12, 2026
- VIS410 high dosePhase 2 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- VIS410 low dosePhase 2 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza APHASE2 · COMPLETED · started Jan 3, 2018ClinicalTrials.gov NCT03040141 · fetched Nov 12, 2026
- Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza APHASE2 · COMPLETED · started Jan 6, 2017ClinicalTrials.gov NCT02989194 · fetched Nov 12, 2026